Stock data
Indivior Pharmaceuticals, Inc. (INDV)
Indivior Pharmaceuticals, Inc. (INDV) reported revenue of US$1.24B and net income of US$210.00M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$1.24B | US$994.00M | US$262.00M | US$210.00M | — |
| 2024 | US$1.19B | US$957.00M | US$38.00M | US$7.00M | — |
| 2023 | US$1.09B | US$919.00M | -US$152.00M | -US$126.00M | — |
| 2022 | US$901.00M | US$749.00M | -US$81.00M | -US$44.00M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$343.00M | US$122.00M | — |
| 2026-03-31 | US$317.00M | US$89.00M | — |
| 2025-12-31 | US$357.00M | US$103.00M | — |
| 2025-09-30 | US$314.00M | US$42.00M | — |
| 2025-06-30 | US$302.00M | US$18.00M | — |
| 2025-03-31 | US$266.00M | US$47.00M | — |
| 2024-12-31 | — | US$21.00M | — |
| 2024-09-30 | US$307.00M | US$22.00M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.